Xiaomin Wan
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Pancreatic and Hepatic Oncology Research
-
- Lung Cancer Treatments and Mutations
- Renal cell carcinoma treatment
- Gastric Cancer Management and Outcomes
Papers in
- Oncology 17
- Cancer Immunotherapy and Biomarkers 12
-
- Renal cell carcinoma treatment 5
- Lung Cancer Treatments and Mutations 5
- Co-authors
- Chongqing Tan (53 shared papers)Xiaohui Zeng (41 shared papers)Liubao Peng (36 shared papers)Xia Luo (23 shared papers)Yucong Zhang (3 shared papers)Lidan Yi (26 shared papers)Sini Li (27 shared papers)Jianhe Li (14 shared papers)
- Journals
- Frontiers in Pharmacology (14 papers)Advances in Therapy (10 papers)PLoS ONE (8 papers)Clinical Therapeutics (5 papers)PharmacoEconomics (4 papers)
- Partner nations
- ChinaAustraliaUnited Kingdom
In The Last Decade
Xiaomin Wan
70 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 81
- Oncology 309
- Pulmonary and Respiratory Medicine 286
- Hepatology 41
- Otorhinolaryngology 12
- Cancer Research 36
Countries citing papers authored by Xiaomin Wan
This map shows the geographic impact of Xiaomin Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomin Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomin Wan more than expected).
Fields of papers citing papers by Xiaomin Wan
This network shows the impact of papers produced by Xiaomin Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomin Wan. The network helps show where Xiaomin Wan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaomin Wan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 134 | |
| 2 | 2019 | 91 | |
| 3 | 2013 | 42 | |
| 4 | 2019 | 41 | |
| 5 | 2015 | 40 | |
| 6 | 2012 | 38 | |
| 7 | 2015 | 38 | |
| 8 | 2009 | 36 | |
| 9 | 2019 | 30 | |
| 10 | 2013 | 24 | |
| 11 | 2014 | 23 | |
| 12 | 2020 | 22 | |
| 13 | 2021 | 20 | |
| 14 | 2022 | 19 | |
| 15 | 2021 | 19 | |
| 16 | 2019 | 18 | |
| 17 | 2017 | 18 | |
| 18 | 2018 | 16 | |
| 19 | 2022 | 16 | |
| 20 | 2022 | 15 |
About Xiaomin Wan
Xiaomin Wan is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Economics and Econometrics, Surgery and Rheumatology, having authored 71 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), Economic and Financial Impacts of Cancer (7 papers), Renal cell carcinoma treatment (5 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), Lung Cancer Treatments and Mutations (5 papers), Bladder and Urothelial Cancer Treatments (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Multiple Myeloma Research and Treatments (3 papers). The work is most often cited by research in Oncology (309 citations), Pulmonary and Respiratory Medicine (286 citations), Hepatology (41 citations), Otorhinolaryngology (12 citations) and Cancer Research (36 citations). Xiaomin Wan has collaborated with scholars based in China, Australia and United Kingdom. Frequent co-authors include Chongqing Tan, Xiaohui Zeng, Liubao Peng, Xia Luo, Yucong Zhang, Lidan Yi, Sini Li, Jianhe Li, Qiao Liu and Peng Ye. Their work appears in journals such as Frontiers in Pharmacology, Advances in Therapy, PLoS ONE, Clinical Therapeutics and PharmacoEconomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.